» Articles » PMID: 29263209

Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies

Overview
Journal Pharmacol Rev
Specialty Pharmacology
Date 2017 Dec 22
PMID 29263209
Citations 117
Authors
Affiliations
Soon will be listed here.
Abstract

Epilepsy is a common and serious neurologic disease with a strong genetic component. Genetic studies have identified an increasing collection of disease-causing genes. The impact of these genetic discoveries is wide reaching-from precise diagnosis and classification of syndromes to the discovery and validation of new drug targets and the development of disease-targeted therapeutic strategies. About 25% of genes identified in epilepsy encode ion channels. Much of our understanding of disease mechanisms comes from work focused on this class of protein. In this study, we review the genetic, molecular, and physiologic evidence supporting the pathogenic role of a number of different voltage- and ligand-activated ion channels in genetic epilepsy. We also review proposed disease mechanisms for each ion channel and highlight targeted therapeutic strategies.

Citing Articles

Transcriptomic analyses of human brains with Alzheimer's disease identified dysregulated epilepsy-causing genes.

Eteleeb A, Alves S, Buss S, Shafi M, Press D, Garcia-Cairasco N medRxiv. 2025; .

PMID: 39974070 PMC: 11838929. DOI: 10.1101/2025.01.02.25319900.


Advancements in Surgical Therapies for Drug-Resistant Epilepsy: A Paradigm Shift towards Precision Care.

Zhong C, Yang K, Wang N, Yang L, Yang Z, Xu L Neurol Ther. 2025; 14(2):467-490.

PMID: 39928287 PMC: 11906941. DOI: 10.1007/s40120-025-00710-4.


Identification and verification of autophagy-related gene signatures and their association with immune infiltration and drug responsiveness in epilepsy.

He H, Zhang X, Chen F Front Neurol. 2025; 15:1503632.

PMID: 39911741 PMC: 11794110. DOI: 10.3389/fneur.2024.1503632.


Chemogenetic Inhibition of Prefrontal Cortex Ameliorates Autism-Like Social Deficits and Absence-Like Seizures in a Gene-Trap Haploinsufficiency Mouse Model.

Ma K, McDaniel K, Zhang D, Webb M, Qin L Genes (Basel). 2025; 15(12.

PMID: 39766886 PMC: 11675260. DOI: 10.3390/genes15121619.


Cannabichromene from full-spectrum hemp extract exerts acute anti-seizure effects through allosteric activation of GABA receptors.

Wang Z, Zheng H, Yang H, Song H, Lian J, Peng C Fundam Res. 2024; 4(6):1357-1364.

PMID: 39734535 PMC: 11670702. DOI: 10.1016/j.fmre.2023.05.023.


References
1.
Caddick S, Wang C, Fletcher C, Jenkins N, Copeland N, Hosford D . Excitatory but not inhibitory synaptic transmission is reduced in lethargic (Cacnb4(lh)) and tottering (Cacna1atg) mouse thalami. J Neurophysiol. 1999; 81(5):2066-74. DOI: 10.1152/jn.1999.81.5.2066. View

2.
Zuberi S, Eunson L, Spauschus A, De Silva R, Tolmie J, Wood N . A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain. 1999; 122 ( Pt 5):817-25. DOI: 10.1093/brain/122.5.817. View

3.
Lerche H, Biervert C, Alekov A, Schleithoff L, Lindner M, Klinger W . A reduced K+ current due to a novel mutation in KCNQ2 causes neonatal convulsions. Ann Neurol. 1999; 46(3):305-12. DOI: 10.1002/1531-8249(199909)46:3<305::aid-ana5>3.0.co;2-5. View

4.
Hirose S, Iwata H, Akiyoshi H, Kobayashi K, Ito M, Wada K . A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. Neurology. 1999; 53(8):1749-53. DOI: 10.1212/wnl.53.8.1749. View

5.
Jun K, Piedras-Renteria E, Smith S, Wheeler D, Lee S, Lee T . Ablation of P/Q-type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)-subunit. Proc Natl Acad Sci U S A. 1999; 96(26):15245-50. PMC: 24805. DOI: 10.1073/pnas.96.26.15245. View